News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,329 Results
Type
Article (42064)
Company Profile (295)
Press Release (667970)
Section
Business (210243)
Career Advice (2086)
Deals (36608)
Drug Delivery (100)
Drug Development (82913)
Employer Resources (172)
FDA (16516)
Job Trends (15373)
News (355649)
Policy (33850)
Tag
Academia (2574)
Alliances (51288)
Alzheimer's disease (1316)
Approvals (16480)
Artificial intelligence (192)
Bankruptcy (364)
Best Places to Work (11751)
Biotechnology (188)
Breast cancer (216)
Cancer (1614)
Cardiovascular disease (129)
Career advice (1744)
CAR-T (112)
Cell therapy (325)
Clinical research (66584)
Collaboration (622)
Compensation (317)
COVID-19 (2627)
C-suite (144)
Data (1521)
Diabetes (196)
Diagnostics (6310)
Earnings (86810)
Employer resources (149)
Events (113377)
Executive appointments (529)
FDA (17344)
Funding (553)
Gene therapy (234)
GLP-1 (668)
Government (4467)
Healthcare (18924)
Infectious disease (2725)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16695)
Job creations (4054)
Job search strategy (1489)
Layoffs (452)
Legal (8344)
Lung cancer (236)
Manufacturing (231)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (20207)
Metabolic disorders (532)
Neuroscience (1707)
NextGen: Class of 2025 (6632)
Non-profit (4521)
Northern California (1930)
Obesity (304)
Opinion (213)
Patents (142)
People (58677)
Phase I (20642)
Phase II (29297)
Phase III (21956)
Pipeline (641)
Postmarket research (2653)
Preclinical (8744)
Radiopharmaceuticals (245)
Rare diseases (312)
Real estate (6245)
Regulatory (22683)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1671)
Startups (3717)
United States (17389)
Vaccines (606)
Weight loss (216)
Date
Today (150)
Last 7 days (635)
Last 30 days (2641)
Last 365 days (35320)
2025 (2647)
2024 (35770)
2023 (40631)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47401)
2018 (35771)
2017 (33139)
2016 (32662)
2015 (38615)
2014 (32520)
2013 (27630)
2012 (29730)
2011 (30491)
2010 (28497)
Location
Africa (776)
Arizona (213)
Asia (40315)
Australia (6455)
California (4423)
Canada (1607)
China (378)
Colorado (200)
Connecticut (211)
Europe (85844)
Florida (635)
Georgia (154)
Illinois (439)
Indiana (257)
Maryland (706)
Massachusetts (3441)
Michigan (190)
Minnesota (323)
New Jersey (1254)
New York (1269)
North Carolina (816)
Northern California (1930)
Ohio (161)
Pennsylvania (1030)
South America (1159)
Southern California (1671)
Texas (653)
Utah (130)
Washington State (442)
710,329 Results for "lupin pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupin Divests U.S. Commercial Women’s Health Specialty Business to Evofem, including SOLOSEC
July 15, 2024
·
5 min read
BioCapital
Lupin Launches Tiotropium Dry Powder for Inhaler for the Treatment of COPD in the United States
Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease in the US. Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic equivalent of Spiriva® HandiHaler®, 18 mcg/capsule of Boehringer Ingelheim Pharmaceuticals, Inc.
August 16, 2023
·
2 min read
Press Releases
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
October 1, 2024
·
5 min read
BioCapital
Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential presence of N-Nitroso-Quinapril Impurity
Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.
December 21, 2022
·
3 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
FDA
Lupin Launches Generic Thiamine Hydrochloride Injection in US
Following the FDA’s approval in March, India-based Lupin is launching its generic thiamine hydrochloride injection USP in the U.S. for treating vitamin B1 deficiency.
June 20, 2023
·
2 min read
·
Tristan Manalac
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
1 of 71,033
Next
